Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
FDA EGRIFTA (tesamorelin) prescribing information approved indication, IGF-1/glucose monitoring, contraindications
Pricing depends on your treatment plan
IGF-1 LR3 transports glucose out of the bloodstream into muscle cells, potentially causing dangerous drops in blood sugar, especially when injected in a fasted state
When possible, only buy peptides from vendors that provide third party lab testing
Trans personalized approach ensures that every injection fits your bodys unique needshelping you feel sharper, stronger, and more balanced
Study 2 (NCT 00435136) This study re-randomized 177 HIV-infected patients with lipodystrophy who completed EGRIFTA treatment in the Main Phase to receive either a 2 mg dose of EGRIFTA (1 mg/vial formulation) (N=92) or placebo (N=85) for an additional 26-week duration (1:1 randomization ratio)
US$ 22.95
US$ 29.51
US$ 25.85
US$ 22.01
US$ 26.19
US$ 19.98
US$ 24.48
US$ 22.66